News

News archive 2015

News

The licensing deal highlights the active role of DelSiTech Ltd in formulation development space of controlled release veterinary drugs.
Approval of its Canadian patent application and filing of a new patent on silica composite formulations strenghtens the Company's leading IPR position is silica based drug delivery technology